About Chris Gibson

I work with amazing scientists, engineers, operators and administrators to invent technological solutions to solve challenges in medicine and biology.

The primary focus of my career has been the founding and building of Recursion, a digital biology company industrializing drug discovery and beyond. Recursion combines automation, artificial intelligence, biology and chemistry with a highly cross-functional team to discover medicines that will change the lives of patients and their families. Over time, as our rich, relatable and proprietary database of petabytes of biological data has grown, we are increasingly moving from an unbiased brute-force search to an autonomous prediction, learning and inference system. The result will turn drug discovery into a many-parameter optimization problem, shift failure earlier in the process and allow for massive parralellization. I believe success of this endeavor in the long run will result in better medicines more quickly and at a reduced cost to society.

I have led the company as CEO since founding through public listing, 4 clinical-stage programs and more than 30 pre-clinical and discovery programs in diverse therapeutic areas. I expect to spend my career building Recursion to achieve our critical mission to decode biology to radically improve lives.

I supplement this work helping advise, mentor and invest in a new generation of diverse biotech founders with passion to make the world better through science.